Open House Biologics Discount Agreements 2025-02 - Rituximab (Subcutaneous Injection Dosage Form)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102119374

  Document Type - Tender Notices

Description - Description: The health insurance companies involved aim to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 of the Social Security Code (SGB V) for the active ingredient Rituximab (a dosage form for subcutaneous injection). The contract is concluded as part of the open house biologics procedure of the health insurance companies involved: Individual negotiations on the contents of the contract are not conducted; uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners exclusivity. The contract term is a maximum of 24 months starting on March 1, 2025. The contract ends

Gt Ref Id - 102119374

Deadline - Feb 28, 2027